Roche commits to diversity & inclusion in the Middle East with the signing of the Middle East Inclusion & Diversity Council Charter
Roche in the Middle East has reaffirmed its commitment to diversity and inclusion by signing the Middle East…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
19 May 23
Roche in the Middle East has reaffirmed its commitment to diversity and inclusion by signing the Middle East…
18 May 23
In the Phase 2 study, which met its primary and secondary endpoints, Roche’s investigational, potent and highly selective…
18 May 23
The task force has already set up two working groups, which will focus on childhood/young adult cancer and…
18 May 23
Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today recognized the progress and…
17 May 23
Astellas and Sony will jointly develop and optimise a new ADC platform using KIRAVIA Backbone as a linker,…
17 May 23
The partnership will combine Scribe Therapeutics’ CRISPR by Design approach with Prevail Therapeutics’ expertise in genetic medicines development…
16 May 23
Arcus will receive an upfront payment of $35m and will commence research programs against up to four targets,…
15 May 23
Veozah is a non-hormonal neurokinin 3 (NK3) receptor antagonist that blocks the activities of the NK3 receptor, which…
15 May 23
Rona Therapeutics will use its RAZOR platform to discover and identify siRNA lead compounds directed to a novel…
15 May 23
Testing supporting allergy diagnosis now accessible to more people in more communities